FrancophonIA/ELRC3.0 huggingface dataset:
English: What Erleada looks like and contents of the pack Erleada film-coated tablets are slightly yellowish to greyish green, oblong-shaped, film-coated tablets (16.7 mm long x 8.7 mm wide), with “AR 60” written on one side.
Slovenian: Erleada filmsko obložene tablete so rahlo rumenkaste do sivozelene podolgovate (16,7 mm dolge in 8,7 mm široke) filmsko obložene tablete, ki imajo na eni strani vtisnjeno oznako “AR 60”.
English: For the active moieties (sum of apalutamide plus the potency adjusted active metabolite), Cmax decreased by 22% while AUC was again similar.
Slovenian: Pri aktivnih frakcijah (vsota apalutamida in aktivnega presnovka s prilagajanjem na potentnost ) se je Cmax zmanjšala za 22%, AUC
English: In a drug-drug interaction study, the Cmax of apalutamide decreased by 22% while AUC was similar following co-administration of Erleada as a 240 mg single dose with itraconazole (strong CYP3A4 inhibitor).
Slovenian: V študiji medsebojnega delovanja med učinkovinama se je Cmax apalutamida zmanjšala za 22%, njegova AUC pa je ostala približno enaka po sočasnem odmerjanju enkratnega odmerka 240 mg zdravila Erleada in itrakonazola (močnega zaviralca CYP3A4).
English: Skin rash led to Erleada treatment discontinuation in 9% of patients who experienced skin rash.
Slovenian: Zaradi kožnega izpuščaja je zdravljenje z zdravilom Erleada prekinilo 9% tistih bolnikov, pri katerih je do izpuščaja prišlo.
English: Erleada may be harmful to a developing foetus.
Slovenian: Zdravilo Erleada lahko škoduje plodu v razvoju.
English: • broken bones
Slovenian: • zlomi kosti
English: A review of concomitant medicinal products should therefore be conducted when apalutamide treatment is initiated.
Slovenian: Zato je na začetku zdravljenja z apalutamidom treba pregledati zdravila, ki jih bolnik sočasno uporablja.
English: Based on its mechanism of action, Erleada may cause foetal harm when administered during pregnancy.
Slovenian: Pri uporabi med nosečnostjo lahko zdravilo Erleada na osnovi svojega mehanizma delovanja škoduje plodu.
English: If given with warfarin, INR should be monitored during Erleada treatment.
Slovenian: Pri sočasni uporabi z varfarinom je treba med zdravljenjem z zdravilom Erleada spremljati internacionalno normalizirano razmerje (INR).
English: However, seizures have been reported in patients taking Erleada.
Slovenian: Vendar pa so pri bolnikih, ki so prejemali zdravilo Erleada, poročali o epileptičnih krčih.
English: When substrates of CYP2B6 (e.g., efavirenz) are administered with Erleada, monitoring for an adverse reaction and evaluation for loss of efficacy of the substrate should be performed and dose adjustment of the substrate may be required to maintain optimal plasma concentrations.
Slovenian: Pri uporabi zdravil, ki so substrati CYP2B6, (kot je efavirenz) sočasno z zdravilom Erleada je treba spremljati neželene učinke in oceniti izgubo učinka substrata ter za zagotovitev optimalnih plazemskih koncentracij morda prilagoditi odmerek substrata.
English: Eighty-one percent of patients had resolution of rash with a median of 60 days to resolution.
Slovenian: Pri enainosemdesetih odstotkih bolnikov je izpuščaj povsem izzvenel v času mediano 60 dni.
English: Erleada decreased the relative risk of distant metastasis or death by 70% compared to placebo (HR = 0.30;
Slovenian: Zdravilo Erleada je zmanjšalo relativno tveganje za pojav oddaljenih metastaz ali smrti za 70% v primerjavi s placebom (HR = 0,30; 95% IZ: 0,24; 0,36; p < 0,0001).
English: Renal impairment No dose adjustment is necessary for patients with mild to moderate renal impairment.
Slovenian: Okvara ledvic Bolnikom z blago do zmerno okvaro ledvic odmerka ni treba prilagajati.
English: • falls
Slovenian: • padci
English: PHARMACEUTICAL FORM AND CONTENTS 112 film-coated tablets
Slovenian: 112 filmsko obloženih tablet
English: Τηλ: +357 22 207 700
Slovenian: CY-2234 Λευκωσία Τηλ: ++357 22 207 700
English: Erleada 60 mg film-coated tablets apalutamide
Slovenian: Erleada 60 mg filmsko obležene tablete apalutamid
English: Skin rash included rash, rash maculo-papular, rash generalised, urticaria, rash pruritic, rash macular, conjunctivitis, erythema multiforme, rash papular, skin exfoliation, genital rash, rash erythematous, stomatitis, drug eruption, mouth ulceration, rash pustular, blister, papule, pemphigoid, skin erosion, and rash vesicular.
Slovenian: Izraz kožni izpuščaj je vključeval izpuščaj, makulopapulozni izpuščaj, generaliziran izpuščaj, urtikarijo, srbeč izpuščaj, makulozen izpuščaj, konjunktivitis, multiformni eritem, papulozni izpuščaj, luščenje kože, genitalni izpuščaj, eritematozni izpuščaj, stomatitis, izpuščaj zaradi zdravil, razjede v ustih, pustulozni izpuščaj, nastanek mehurja, papulo, pemfigoid, kožno erozijo in mehurčkast izpuščaj.
English: Your doctor may also prescribe other medicines while you are taking Erleada.
Slovenian: V času jemanja zdravila Erleada vam zdravnik lahko predpiše tudi druga zdravila.
English: No initial dose adjustment is necessary when Erleada is co-administered with a strong inhibitor of CYP2C8 (e.g., gemfibrozil, clopidogrel) however, a reduction of the Erleada dose based on tolerability should be considered (see section 4.2).
Slovenian: Pri sočasnem odmerjanju zdravila Erleada s katerim od močnih zaviralcev CYP2C8 (kot sta gemfibrozil in klopidogrel) začetnega odmerka ni treba prilagajati, premisliti pa velja o zmanjšanju odmerka zdravila Erleada na osnovi prenašanja zdravila (glejte poglavje 4.2).
English: Erleada is co-administered with a strong inhibitor of CYP3A4 (e.g., ketoconazole, ritonavir, clarithromycin) however, a reduction of the Erleada dose based on tolerability should be considered (see section 4.2).
Slovenian: Pri sočasnem odmerjanju zdravila Erleada s katerim od močnih zaviralcev CYP3A4 (kot sta ketokonazol, ritonavir in klaritromicin) začetnega odmerka ni treba prilagajati, premisliti pa velja o zmanjšanju odmerka zdravila Erleada na osnovi prenašanja zdravila (glejte poglavje 4.2).
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTER 60 mg (12 count) (Blister sealed in inner wallet)
Slovenian: PRETISNI OMOT 60 mg (12 tablet) (pretisni omot zaprt v notranji zloženki)
English: 24 film-coated tablets each.
Slovenian: 24 filmsko obloženih tablet v eni zloženki
English: The side effects for Erleada include seizures.
Slovenian: Med neželenimi učinki zdravila Erleada so napadi krčev.
English: PHARMACEUTICAL FORM AND CONTENTS 120 film-coated tablets
Slovenian: 120 filmsko obloženih tablet
English: The racial distribution was 66% Caucasian, 5.6% Black, 12% Asian, and 0.2% Other.
Slovenian: Porazdelitev glede na raso je bila 66% belcev, 5,6% pripadnikov črne rase, 12% pripadnikov azijske rase in 0,2% pripadnikov drugih ras. Sedeminsedemdeset odstotkov (77%) preiskovancev v obeh študijskih skupinah je predhodno že imelo operiracijo ali obsevanje prostate.
English: Each 28-day carton contains 112 film-coated tablets in 4 cardboard wallet packs of 28 film-coated tablets each.
Slovenian: Ena škatla z 28-dnevnim pakiranjem vsebuje 112 filmsko obloženih tablet v 4 kartonskih zloženkah, od katerih vsaka vsebuje 28 filmsko obloženih tablet.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS BLISTER 60 mg (16 count) (Blister sealed in inner wallet)
Slovenian: PRETISNI OMOT 60 mg (16 tablet) (pretisni omot zaprt v notranji zloženki)
English: Mean (CV%) AUC metabolite/parent drug ratio for N-desmethyl apalutamide following repeat-dose administration was about 1.3 (21%).
Slovenian: Pri ponavljajočem odmerjanju je bila povprečna vrednost razmerja med AUC presnovka in AUC matične učinkovine za N-desmetil apalutamid 1,3 (s koeficientom variacije 21%).
English: Discard unused contents appropriately in accordance with local requirements.
Slovenian: Neuporabljeno zdravilo zavrzite v skladu z lokalnimi predpisi.
English: Each 30-day carton contains 120 film-coated tablets in 5 cardboard wallet packs of 24 film-coated tablets each.
Slovenian: Ena škatla s 30-dnevnim pakiranjem vsebuje 120 filmsko obloženih tablet v 5 kartonskih zloženkah, od katerih vsaka vsebuje 24 filmsko obloženih tablet.
English: How to take Erleada
Slovenian: Kako jemati zdravilo Erleada
English: When substrates of UGT are co-administered with Erleada, evaluation for loss of efficacy of the substrate should be performed and dose adjustment of the substrate may be required to maintain optimal plasma concentrations.
Slovenian: Če je treba substrate UDP-glukuronil transferaze uporabljati sočasno z zdravilom Erleada, je pri tem potrebna previdnost in ocena obsega zmanjšanja učinka ter za zagotovitev optimalnih plazemskih koncentracij morda prilagoditi odmerek substrata.
English: 28 film-coated tablets each.
Slovenian: 28 filmsko obloženih tablet v eni zloženki
English: PHARMACEUTICAL FORM AND CONTENTS 120 tablets
Slovenian: 120 tablet
English: Animal reproductive studies have not been conducted with Erleada.
Slovenian: Študij o vplivu zdravila Erleada na sposobnost razmnoževanja na živalih niso izvedli.
English: How to store Erleada
Slovenian: Jemanje zdravila Erleada
English: PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGING BOTTLE LABEL 60 mg
Slovenian: NALEPKA NA PLASTENKI 60 mg
English: • no longer responds to medical or surgical treatment that lowers testosterone (also called castration-resistant prostate cancer).
Slovenian: Uporabljamo ga za zdravljenje odraslih moških z rakom prostate, pri katerih: - rak ni metastaziral na druge dele telesa, - se bolezen ne odziva več na medikamentno ali kirurško zdravljenje, ki znižuje koncentracijo testosterona (kar se imenuje na kastracijo odporen rak prostate).
English: Drug metabolising enzymes
Slovenian: Encimi, ki presnavljajo zdravila
English: Fill in your weekdays Start date:
Slovenian: Vpišite dneve v tednu.
English: Seizure
Slovenian: Konvulzije
English: Talk to your doctor if you have any questions about contraception.
Slovenian: Če imate glede kontracepcije še kakršna koli vprašanja, se pogovorite z zdravnikom.
English: Broken bones have been observed in patients taking Erleada.
Slovenian: Pri bolnikih, ki jemljejo zdravilo Erleada so opazili zlome kosti.
English: Apalutamide was negative for genotoxicity in a standard battery of in vitro and in vivo tests.
Slovenian: V standardnem setu testiranj in vitro in in vivo apalutamid ni bil genotoksičen.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON 60 mg (28 days)
Slovenian: ZUNANJA ZLOŽENKA 60 mg (28 dni)
English: • you are taking any medicines to prevent blood clots (e.g., warfarin, acenocoumarol) • you have any heart or blood vessel conditions, including heart rhythm problems (arrhythmia)
Slovenian: - če imate katero koli bolezen srca ali ožilja, vključno z motnjami srčnega ritma (aritmije)
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON 60 mg (30 days)
Slovenian: ZUNANJA ZLOŽENKA 60 mg (30 dni)
English: Your healthcare provider may monitor you more closely if you are at risk for fractures.
Slovenian: Če pri vas obstaja tveganje za zlome vas bo morda zdravnik pogosteje spremljal.
English: • Keep this leaflet.
Slovenian: • kožni izpuščaj
English: Contents of the pack and other information What Erleada contains
Slovenian: Shranjevanje zdravila Erleada Vsebina pakiranja in dodatne informacije
English: Your healthcare provider will stop Erleada if you have a seizure during treatment.
Slovenian: Če med zdravljenjem pride do napada krčev, vam bo zdravnik ukinil zdravilo
English: Treatment with Erleada significantly improved MFS.
Slovenian: Zdravljenje z zdravilom Erleada je statistično značilno izboljšalo preživetje brez pojava metastaz.
English: NAME OF THE MARKETING AUTHORISATION HOLDER Janssen-Cilag International NV
Slovenian: Janssen-Cilag International NV
English: C-labeled apalutamide 240 mg, apalutamide, the active metabolite, N-desmethyl apalutamide, and an inactive carboxylic acid metabolite accounted for the majority of the 14C-radioactivity in plasma, representing 45%, 44%, and 3%, respectively, of the total 14C-AUC.
Slovenian: C označenega apalutamida so apalutamid, njegov aktivni presnovek N-desmetil apalutamid in neaktivni karboksilnokislinski presnovek prispevali večino
English: A drug-drug interaction study using a cocktail approach showed that co-administration of Erleada with single oral doses of sensitive transporter substrates resulted in a 30% decrease in the AUC of fexofenadine (P-gp substrate) and 41% decrease in the AUC of rosuvastatin (BCRP/OATP1B1 substrate) but had no impact on Cmax.
Slovenian: V študiji interakcij z uporabo mešanice substratov je sočasno odmerjanje zdravila Erleada z enkratnimi peroralnimi odmerki občutljivih substratov prenašalcev povzročilo 30% zmanjšanje AUC feksofenadina (substrata P-gp) in
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGING CARTON 60 mg (BOTTLE)
Slovenian: ŠKATLA 60 mg (PLASTENKA)
English: Falls have been observed in patients taking Erleada.
Slovenian: Pri bolnikih, ki jemljejo zdravilo Erleada so opazili padce.
English: Bottle
Slovenian: Plastenka
English: NAME OF THE MEDICINAL PRODUCT Erleada 60 mg film-coated tablets
Slovenian: Erleada 60 mg filmsko obložene tablete
English: • Each 28-day carton contains 112 film coated tablets in 4 cardboard wallet packs of
Slovenian: • Eno 28-dnevno pakiranje vsebuje 112 filmsko obloženih tablet v 4 kartonskih zgibankah, od katerih vsaka vsebuje 28 filmsko obloženih tablet.
English: • Each 30-day carton contains 120 film coated tablets in 5 cardboard wallet packs of
Slovenian: • Eno 30-dnevno pakiranje vsebuje 120 filmsko obloženih tablet v 5 kartonskih zgibankah, od katerih vsaka vsebuje 24 filmsko obloženih tablet.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS INNER WALLET 60 mg (28 days)
Slovenian: NOTRANJA ZLOŽENKA 60 mg (28 dni)
English: STATEMENT OF ACTIVE SUBSTANCE(S) Each tablet contains 60 mg apalutamide.
Slovenian: Ena tableta vsebuje 60 mg apalutamida.
English: The elimination of apalutamide and formation of its active metabolite, N-desmethyl apalutamide, is mediated by both CYP2C8 and CYP3A4 to a similar extent at steady-state.
Slovenian: V stanju dinamičnega ravnovesja encima CYP2C8 in CYP3A4 v enaki meri posredujeta odstranjevanje apalutamida in tvorbo njegovega aktivnega presnovka, N-desmetil apalutamida.
English: • take this package leaflet with you to show to the emergency doctor.
Slovenian: Če zdravilo Erleada pomotoma vzame otrok ali mladostnik: - pojdite takoj v bolnišnico, - s seboj vzemite to navodilo za uporabo in ga pokažite zdravniku na urgenci.
English: MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STRIPS INNER WALLET 60 mg (30 days)
Slovenian: NOTRANJA ZLOŽENKA 60 mg (30 dni)
English: Tell your doctor if you are taking medicines that:
Slovenian: Pripravite seznam zdravil, ki jih jemljete.
English: Taking Erleada
Slovenian: Erleada.
English: These medicines should only be used in adult women.
Slovenian: Ta zdravila se smejo uporabljati samo pri odraslih ženskah.
English: They should not be taken for longer than one week and if symptoms last for more than four days or worsen during the use of the medicine a
Slovenian: Ne smejo se jemati dlje kot en teden, če pa so simptomi prisotni več kot štiri dni ali če se med uporabo zdravila poslabšajo, se je treba posvetovati z zdravnikom ali usposobljenim zdravstvenim delavcem.
English: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom27 March 2018 EMA/181295/2018
Slovenian: 30 Churchill Place ● Canary Wharf ● London E14 5EU ● United Kingdom20.
English: The HMPC conclusions only cover bearberry leaf preparations which are obtained by drying and comminuting (reducing into tiny pieces) or powdering the leaves, or by using a technique to extract compounds by putting the plant material in a solvent (such as ethanol or water) to dissolve compounds and form a liquid extract.
Slovenian: Zaključki odbora HMPC zajemajo samo pripravke z listom vednozelenega gornika, ki se pridobivajo s sušenjem in drobljenjem listov (zmanjševanjem listov na majhne delce), z drobljenjem listov v prah ali z uporabo tehnike, s katero se spojine ekstrahirajo tako, da se rastlinski material najprej namoči v topilo (npr. etanol ali vodo), v katerem se raztopijo spojine in se pridobi tekoči ekstrakt.
English: This summary is not intended to provide practical advice on how to use medicines containing bearberry leaf.
Slovenian: Povzetek ni namenjen zagotavljanju praktičnih nasvetov o uporabi zdravil, ki vsebujejo list vednozelenega gornika.
English: Further information on the risks associated with these bearberry leaf medicines, including the appropriate precautions for their safe use, can be found in the monograph under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o tveganjih, povezanih s temi zdravili, ki vsebujejo list vednozelenega gornika, vključno z ustreznimi previdnostnimi ukrepi za njihovo varno uporabo, so na voljo v monografiji na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: The HMPC concluded that, on the basis of its long-standing use, these bearberry leaf preparations can be used for relief of symptoms of mild, recurrent infections in the lower urinary tract (the structure that carries urine), such as a burning sensation when passing urine and/or frequently passing urine.
Slovenian: Odbor HMPC je na podlagi dolgotrajne uporabe zaključil, da se lahko ti pripravki, ki vsebujejo list vednozelenega gornika, uporabljajo za lajšanje simptomov pri blagih, ponavljajočih se okužbah spodnjih sečil (struktur, po katerih potuje urin), kot sta pekoč občutek pri prehajanju urina in/ali pogosto uriniranje.
English: In its assessment, the HMPC considered laboratory studies which showed bearberry leaf preparations to have antibacterial action.
Slovenian: V svoji oceni je odbor HMPC upošteval laboratorijske študije, ki so pokazale, da pripravki z listom vednozelenega gornika delujejo protibakterijsko.
English: Bearberry leaf is the common name for the leaves of the plant Arctostaphylos uva-ursi (L.) Spreng.
Slovenian: List vednozelenega gornika je splošno ime za liste rastline Arctostaphylos uva-ursi (L.) Spreng.
English: This is a summary of the scientific conclusions reached by the Committee on Herbal Medicinal Products (HMPC) on the medicinal uses of bearberry leaf.
Slovenian: To je povzetek znanstvenih zaključkov Odbora za zdravila rastlinskega izvora (HMPC) v zvezi z medicinsko uporabo lista vednozelenega gornika.
English: The HMPC conclusions on the use of these bearberry leaf medicines for lower urinary tract infections are based on their ‘traditional use'.
Slovenian: Zaključki odbora HMPC v zvezi z uporabo zdravil, ki vsebujejo list vednozelenega gornika, za okužbe spodnjih sečil temeljijo na njihovi „tradicionalni uporabi“.
English: No clinical studies are available with preparations containing only bearberry leaf.
Slovenian: Na voljo ni nobenih kliničnih študij o pripravkih, ki vsebujejo samo list vednozelenega gornika.
English: Herbal medicines containing these bearberry leaf preparations are usually available as herbal tea to be drunk and in liquid or solid forms to be taken by mouth.
Slovenian: Zdravila rastlinskega izvora, ki vsebujejo te pripravke z listom vednozelenega gornika, so navadno na voljo kot zdravilni čaj, ki se popije, in v trdni obliki za jemanje skozi usta.
English: Any applications for the licensing of medicines containing bearberry leaf have to be submitted to the national authorities responsible for medicinal products, which will assess the application for the herbal medicine and take into account the scientific conclusions of the HMPC.
Slovenian: Vlogo za izdajo dovoljenja za promet z zdravili, ki vsebujejo list vednozelenega gornika, je treba predložiti pristojnemu nacionalnemu organu za zdravila, ki bo to vlogo za izdajo dovoljenja za promet z zdravilom rastlinskega izvora ocenil in upošteval znanstvene zaključke odbora HMPC.
English: Further information on the HMPC assessment of bearberry leaf medicines, including details of the Committee's conclusions, can be found under the tab ‘All documents' on the Agency's website: ema.europa.eu/Find medicine/Herbal medicines for human use.
Slovenian: Dodatne informacije o oceni zdravil, ki vsebujejo list vednozelenega gornika, ki jo je opravil odbor HMPC, vključno z njegovimi znanstvenimi zaključki, so na voljo na spletni strani agencije pod zavihkom „Vsi dokumenti“: ema.europa.eu/Find medicine/Herbal medicines for human use.
English: Information on the use and licensing of bearberry leaf medicines in EU Member States should be obtained from the relevant national authorities.
Slovenian: Za informacije o uporabi in registraciji zdravil, ki vsebujejo list vednozelenega gornika, v državah članicah EU se obrnite na pristojni nacionalni organ.
English: Bearberry leaf EMA/181295/2018
Slovenian: List vednozelenega gornika EMA/424828/2016
English: Bearberry leaf preparations may also be found in combination with other herbal substances in some herbal medicines.
Slovenian: Pripravki z listom vednozelenega gornika so v nekaterih zdravilih rastlinskega izvora lahko na voljo tudi v kombinaciji z drugimi rastlinskimi snovmi.
English: The HMPC conclusions are taken into account by EU Member States when evaluating applications for the licensing of herbal medicines containing bearberry leaf.
Slovenian: Ugotovitve odbora HMPC države članice EU upoštevajo pri ocenjevanju vlog za izdajo dovoljenja za promet z zdravili rastlinskega izvora, ki vsebujejo list vednozelenega gornika.
English: How are bearberry leaf medicines approved in the EU?
Slovenian: Kako so zdravila, ki vsebujejo list vednozelenega gornika, odobrena v EU?
English: Bearberry leaf preparations should only be used after serious conditions have been excluded by a doctor.
Slovenian: Pripravki, ki vsebujejo list vednozelenega gornika, se smejo uporabljati šele, ko zdravnik izključi resnejša stanja.
English: Detailed instructions on how to take bearberry leaf medicines and who can use them can be found in the package leaflet that comes with the medicine.
Slovenian: Podrobna navodila o jemanju zdravil, ki vsebujejo list vednozelenega gornika, in o tem, kdo sme ta zdravila jemati, so na voljo v navodilu za uporabo, ki je priloženo posameznemu zdravilu.
English: What evidence supports the use of bearberry leaf medicines?
Slovenian: Kateri dokazi podpirajo uporabo zdravil, ki vsebujejo list vednozelenega gornika?
English: For more information about treatment with bearberry leaf medicines, read the package leaflet that comes with the medicine or contact your doctor or pharmacist.
Slovenian: Za več informacij o zdravljenju z zdravili, ki vsebujejo list vednozelenega gornika, preberite navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujte z zdravnikom ali farmacevtom.
English: Women with kidney disorders must not take bearberry leaf medicines.
Slovenian: Zdravil, ki vsebujejo list vednozelenega gornika, ne smejo jemati ženske z boleznimi ledvic.
English: For practical information about using bearberry leaf medicines, patients should read the package leaflet that comes with the medicine or contact their doctor or pharmacist.
Slovenian: Za praktične informacije o njihovi uporabi naj bolniki preberejo navodilo za uporabo, ki je priloženo posameznemu zdravilu, ali se posvetujejo z zdravnikom ali farmacevtom.
English: Other information about bearberry leaf medicines
Slovenian: Druge informacije o zdravilih, ki vsebujejo list vednozelenega gornika
English: What are the risks associated with bearberry leaf medicines?
Slovenian: Kakšna tveganja so povezana z zdravili, ki vsebujejo list vednozelenega gornika?
English: What is bearberry leaf?
Slovenian: Kaj je list vednozelenega gornika?
English: Bearberry leaf
Slovenian: List vednozelenega gornika
English: For dry extracts, the solvent is then evaporated.
Slovenian: Topilo se nato odpari, s čimer se pridobi suhi ekstrakt.
English: Nausea, vomiting and stomach ache are side effects that have been reported with bearberry leaf medicines.
Slovenian: Neželeni učinki, o katerih so poročali pri uporabi zdravil, ki vsebujejo list vednozelenega gornika, so navzeja (slabost), bruhanje in bolečine v trebuhu.